Mitral Valve Disease: Clinical Trials

4 trials for Mitral Valve Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Mitral Valve Disease: new trials by email Literature Review of Mitral Valve Disease trials Research Report on Mitral Valve Disease

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Microplegia on Transfusion Rates After Cardiac Surgery
Cardioplegia Solution, Microplegic Solution No. 1 - Aortic Valve Disease, Mitral Valve Disease
Phase 4CompletedWashington University School of Medicine3142019-03-252024-08-06
ESP vs ESP With PECS
Erector Spinae Plane blockade, Pectoral Fascia block, Oxycodone - Postoperative Pain, Mitral Valve Disease
Phase 4CompletedMedical University of Lublin332018-06-282019-03-01
Warfarin Initiation in Mechanical Mitral Valve Replacement Patients
Warfarin Sodium 5 MG, Warfarin Sodium 3 MG, Enoxaparin Sodium 100 MG/ML Prefilled Syringe - Mitral Valve Disease
Phase 4CompletedSarah Sabry Hashem502018-03-012020-01-27
Postoperative Analgesia After Minithoracotomy
Erector Spinae Plane blockade, Oxycodone, general anesthesia - Postoperative Pain, Mitral Valve Disease
Phase 4CompletedMedical University of Lublin192018-02-072023-11-28

Narrower conditions

Pain, Postoperative (2)  ·  Aortic Valve Disease (1)

Broader conditions

Neurologic Manifestations (2)  ·  Pain (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Postoperative Complications (2)  ·  Signs and Symptoms (2)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)

Interventions

Acetaminophen (2)  ·  Anesthesia, General (2)  ·  Oxycodone (2)  ·  Cardioplegic Solutions (1)  ·  Enoxaparin (1)  ·  Passive Cutaneous Anaphylaxis (1)  ·  Warfarin (1)  ·  enoxaparin sodium (1)

Sponsors

Medical University of Lublin (2)  ·  Sarah Sabry Hashem (1)  ·  Washington University School of Medicine (1)

Countries

Poland (2)  ·  Egypt (1)  ·  United States (1)

Top investigators

Ayman M Saleh, MD (1)  ·  Lamiaa M ElWakeel, PhD (1)  ·  Marwa A Ahmed, PhD (1)  ·  Sarah S Hashem, Msc (1)  ·  Spencer J Melby, MD (1)

Results publications

PMID 14771796, PMID 32106812, PMID 35274222